EDMONTON, Alberta, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that its common shares commenced trading today on the OTCQX Best Market under the symbol “RDDTF”. Radient’s common shares will continue trading on the TSX Venture Exchange under the symbol “RTI”.



Dorsey & Whitney LLP acted as the Company’s OTCQX Best Market sponsor and advisor.

The OTCQX Best Market, a US trading platform operated by the OTC Markets Group in New York, is a market for established, investor-focused U.S. and international companies. Companies traded on the OTCQX Best Market are required to meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, be current in their disclosure and have been sponsored by a professional third-party advisor. The OTCQX Best Market includes real-time quotes while providing timely news and disclosure to investors. Market information for Radient is available at www.otcmarkets.com /stock/RDDTF/quote .

“With our recent announcements of additional manufacturing facilities to be built in Edmonton and Germany, we are preparing for what should prove to be a milestone period of growth for the Company,” said Denis Taschuk, President and CEO of Radient. “We look forward to increasing Radient’s visibility and accessibility amongst investors in the US while also building liquidity for the Company, and we believe trading on OTCQX is a key part of that process.”

About Radient

Radient extracts natural compounds from a range of biological materials using microwave assisted processing (“MAP™”), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 23,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, and personal care markets. Since 2016, Radient has expanded its offerings to enter the cannabinoids market utilizing its MAP™ platform to process and extract cannabinoids including cannabidiol and tetrahydrocannabinol from cannabis biomass. Visit www.radientinc.com for more information.

SOURCE: Radient Technologies Inc.

Denis Taschuk, Chief Executive Officer, dtaschuk@radientinc.com ,

(780) 465-1318;

Mike Cabigon, Chief Operating Officer, mcabigon@radientinc.com ,

(780) 465-1318

Caitlin Cheadle, Director of Communications, ccheadle@radientinc.com

Forward Looking Information:

This press release contains “forward-looking information” and “forward looking statements” within the meaning of applicable Canadian and United States securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.